When will Anduril officially announce an IPO?

Anduril achieved significant financial and contract milestones in early 2026. On May 13, 2026, the company closed a $5 billion Series H funding round, which doubled its post-money valuation to $61 billion ^{[^]}. Additionally, in March 2026, Anduril secured a substantial 10-year enterprise contract with the Army, potentially valued at $20 billion ^{[^][^][^]}.

The substantial Army contract detailed specific platform integration and production targets. The March 2026 agreement specifies Anduril will integrate its commercial platforms, including the Lattice AI suite, to create a unified mission-ready capability for the Army ^{[^][^][^]}. Furthermore, Anduril is actively scaling production of its Barracuda-500M cruise missiles, aiming to produce "single-digit thousands" by the end of 2026. This initiative supports an agreement to supply the Army with at least 3,000 units annually, commencing in 2027 ^{[^][^]}.

Despite market speculation, Anduril executives temper immediate IPO expectations. These achievements have led to market speculation regarding a potential $100 billion initial public offering (IPO) listing in late 2026 ^{[^]}. However, Anduril executives have previously indicated that the company is not on a "rapid path" to an IPO, instead preparing for a medium-term exit ^{[^][^]}.

Anduril recently secured substantial Series H funding, reaching a high valuation. The company closed a $5 billion Series H funding round on May 13, 2026, which effectively doubled its valuation to $61 billion ^{[^][^]}.

Anduril has not yet filed for an IPO, despite co-founder's intent. As of May 27, 2026, Anduril had not filed for an Initial Public Offering (IPO), and no official filing date has been publicly announced ^{[^][^][^][^]}. While co-founder Palmer Luckey has confirmed the company's intention to go public, he did not provide a specific timeline ^{[^][^]}. An SEC S-1 filing discovered on May 26, 2026, was confirmed to be for Firefly Aerospace and unrelated to Anduril ^{[^]}. The resolution of prediction markets regarding an Anduril IPO is expected to depend on a future company announcement, rather than the recent Series H funding close ^{[^][^]}.

Anduril Industries' current valuation and revenue multiples are higher than Palantir's at its public debut. As of May 2026, Anduril is valued at $61 billion, with an implied valuation-to-revenue multiple of approximately 27.7x. In contrast, Palantir Technologies went public on September 30, 2020, with an initial market capitalization of $16.5 billion, corresponding to an implied valuation-to-revenue multiple of approximately 15.6x ^{[^][^][^][^]}.

Anduril's valuation surged after a recent significant funding round. Specifically, Anduril Industries achieved its $61 billion valuation in May 2026 following a $5 billion Series H funding round. This valuation, when considered against its projected 2025 fiscal year revenue of $2.2 billion, results in the valuation-to-revenue multiple of approximately 27.7x ^{[^][^]}.

Palantir's debut valuation was lower with a smaller multiple. Palantir Technologies' direct listing on September 30, 2020, established an initial market capitalization of $16.5 billion. Based on a projected full-year revenue for 2020 of approximately $1.06 billion, its implied valuation-to-revenue multiple at that time was about 15.6x ^{[^][^]}. Despite Anduril's high valuation, prediction markets as of May 2026 indicate significant skepticism regarding an imminent IPO, with single-digit odds for a public offering occurring before 2027 ^{[^][^][^]}.

The public S-1 filing is the definitive signal of an impending IPO. The definitive public signal of an impending Initial Public Offering (IPO) is the public filing of the S-1 registration statement (or S-1/A amendment) on the SEC's EDGAR system ^{[^][^]}. Companies can initially submit a draft S-1 confidentially to the SEC, but this non-public submission does not serve as a public announcement of intent ^{[^][^][^]}. This confidential process allows for private review and revisions with the SEC, deferring public disclosure of sensitive information and offering flexibility to withdraw from the IPO process without public attention if market conditions are unfavorable ^{[^][^][^]}. This confidential S-1 draft must eventually be made public, typically at least 15 days before the company's roadshow or the requested effective date of the registration statement ^{[^][^][^][^][^]}. The public S-1 filing contains comprehensive details about the company's business, financials, risk factors, and management, signaling the formal start of the public offering process ^{[^][^][^][^][^]}.

Anduril has not yet officially filed for an Initial Public Offering. As of May 2026, Anduril has not officially filed for an IPO ^{[^][^][^][^][^]}, though its Executive Chairman indicated in June 2025 that an IPO is a "medium term" goal, not a "rapid path" ^{[^]}.

Anduril has not specified macroeconomic conditions for its potential IPO. The company has not officially announced an IPO date, nor has it publicly identified specific macroeconomic thresholds, such as the VIX trading below 20, as prerequisites for its market entry. However, industry projections and statements from the founder suggest a potential public market debut in late 2026 or 2027 ^{[^]}. Key internal milestones for an IPO include achieving profitability and demonstrating operational success at new manufacturing facilities, such as its Ohio plant, which began production in March 2026 ^{[^]}.

Recent substantial funding allows Anduril to delay its public offering. In May 2026, Anduril secured a $5 billion Series H funding round, which increased its valuation to $61 billion ^{[^][^][^]}. Management has indicated that this significant capital provides ample resources to postpone public market entry until the company's financial figures are more established ^{[^][^][^]}.

An immediate catalyst for a change in market probability would be a verified, company-confirmed IPO announcement date, which has not occurred as of 2026-05-27. Forge states that Anduril has not filed for an IPO, meaning IPOs are not yet "officially" timed ^{[^]}. An IPO would be officially announced if an SEC Form S-1 becomes effective, the IPO is priced, or a ticker is assigned ^{[^]}.

Prediction markets reflect skepticism regarding a near-term listing. A Solflare contract, "When will Anduril officially announce an IPO?", shows probabilities of 31% for "Before Jun 1, 2027" and 29% for "Before May 1, 2027" ^{[^]}. The Polymarket contract, "Anduril Industries IPO before 2027?", shows 92% NO as of its cited listing view, with a Dec 31, 2026 deadline ^{[^]}. This sentiment is reinforced by an OddsShift snapshot from Apr 4, 2026, which reported only ~8% probability for an "Anduril IPO before 2027" ^{[^]}. The company's recent $5B Series H round on May 13, 2026, which valued it at $61B, may also influence the timing of a public offering ^{[^][^]}.